tradingkey.logo
搜尋

Codexis Inc

CDXS
添加自選
1.400USD
-0.080-5.41%
收盤 07-31 16:00美東報價延遲15分鐘
150.59M總市值
虧損本益比TTM

關於 Codexis Inc 公司

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Inc簡介

公司代碼CDXS
公司名稱Codexis Inc
上市日期Apr 22, 2010
CEOMoore (Alison)
員工數量188
證券類型Ordinary Share
年結日Apr 22
公司地址200 Penobscot Dr
城市REDWOOD CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94063
電話16504218100
網址https://www.codexis.com/
公司代碼CDXS
上市日期Apr 22, 2010
CEOMoore (Alison)

Codexis Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
84.81K
-3.07%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--

常見問題

Codexis Inc的前五大股東是誰?

Codexis Inc的前五大股東如下:Dr. Alison Moore, Ph.D.

有多少機構持有Codexis Inc(CDXS)的股份?

截至2026Q1,共有273家機構持有Codexis Inc的股份,合計持有的股份價值約為66.34M,占公司總股份的73.00% 。與2025Q4相比,機構持股有所增加,增幅為-13883230.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有